Key result
Highest NT-proBNP quintile linked to ~3-fold higher incident HF risk vs. lowest quintile.
Why the study?
Accurate cardiovascular risk stratification is challenging in the elderly, and whether serial NT-proBNP measurements provide additional prognostic information beyond traditional risk factors was unknown.
Does serial measurement of NT-proBNP predict incident heart failure and cardiovascular death in community-dwelling older adults free of heart failure?
Cohort (n=2,975)
Yes
Does serial measurement of NT-proBNP predict incident heart failure and cardiovascular death in community-dwelling older adults free of heart failure?
Answers are grounded in this paper and cite their sources.
Serial measurements of NT-proBNP in older adults provide dynamic prognostic information for incident heart failure and cardiovascular death, improving risk stratification beyond traditional clinical factors.
Objectives Determine if serial measurement of N-terminal pro B-type natriuretic peptide (NT-proBNP) in community dwelling elderly would provide additional prognostic information to traditional risk factors. Background Accurate cardiovascular risk stratification is challenging in the elderly. Methods NT-proBNP was measured at baseline and 2-3 years later in 2,975 community-dwelling older adults free of heart failure in the longitudinal Cardiovascular Health Study. This investigation examined the risk of new-onset heart failure (HF) and death from cardiovascular (CV) causes associated with baseline NT-proBNP and changes in NT-proBNP levels, adjusting for potential confounders. Results NT-proBNP levels in the highest quintile (>267.7 pg/mL) were independently associated with greater risks of HF (hazard ratio [HR] =3.05 (95%CI [confidence interval] 2.46-3.78) and CV death (HR=3.02, 95%CI 2.36-3.86) compared to the lowest quintile (<47.5 pg/mL). The inflection point for elevated risk occurred at NT-proBNP=190 pg/mL. Among participants with initially low NT-proBNP (<190 pg/mL), those who developed a >25% increase on follow-up to >190 pg/mL (21%) were at greater adjusted risk of HF (HR=2.13, 95%CI=1.68-2.71) and CV death (HR=1.91, 95%CI=1.43-2.53) compared to those with sustained low levels. Among participants with initially high NT-proBNP, those who developed >25% increase (40%) were at higher risk of HF (HR=2.06 95%CI 1.56 −2.72) and cardiovascular death (HR=1.88, 95%CI 1.37-2.57), whereas those who developed >25% decrease to ≤190pg/mL (15%) were at lower risk of HF (HR=0.58, 95%CI 0.36-0.93) and CV death (HR=0.57, 95%CI 0.32 −1.01) compared to those with unchanged high values. Conclusion NT-proBNP levels independently predict heart failure and cardiovascular death in older adults. NT-proBNP levels frequently change over time and these fluctuations reflect dynamic changes in cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
deFilippi et al. (2010) conducted a cohort in Community-dwelling older adults free of heart failure (n=2,975). Baseline and serial NT-proBNP levels vs. Lowest quintile of NT-proBNP or unchanged levels was evaluated on Incident heart failure (HR 3.05, 95% CI 2.46-3.78). Baseline NT-proBNP levels in the highest quintile were independently associated with a greater risk of incident heart failure compared to the lowest quintile.
Synapse has enriched 10 related papers. Consider them for comparative context: